Microarray analysis of human nervous system gene expression in neurological disease

International Review of Neurobiology

Volumn 60, Issue , 2004, Pages 135-151

  Greenberg, Steven A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; ANIMAL; BRAIN TUMOR; CLASSIFICATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; METHODOLOGY; MICROARRAY ANALYSIS; MULTIPLE SCLEROSIS; NERVOUS SYSTEM; NEUROLOGIC DISEASE; NEUROMUSCULAR DISEASE; PHYSIOLOGY; REVIEW;

ALZHEIMER DISEASE; ANIMALS; BRAIN NEOPLASMS; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMANS; MICROARRAY ANALYSIS; MULTIPLE SCLEROSIS; NERVOUS SYSTEM; NERVOUS SYSTEM DISEASES; NEUROMUSCULAR DISEASES;

EID: 16544394995     PISSN: 00747742     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0074-7742(04)60005-5     Document Type: Article

References (85)

1. Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S., Rosenwald, A., Boldrick, J. C., Sabet, H., Tran, T., Yu, X., Powell, J. I., Yang, L., Marti, G. E., Moore, T., Hudson, J., Jr., Lu, L., Lewis, D. B., Tibshirani, R., Sherlock, G., Chan, W. C., Greiner, T. C., Weisenburger, D. D., Armitage, J. O., Warnke, R., Staudt, L. M., et al. (2000). Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403, 503-511 .
2. Baechler, E. C., Batliwalla, F. M., Karypis, G., Gaffney, P. M., Ortmann, W. A., Espe, K. J., Shark, K. B., Grande, W. J., Hughes, K. M., Kapur, V., Gregersen, P. K., and Behrens, T. W. (2003). Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc. Natl. Acad. Sci. USA 100, 2610-2615.
3. Baldi, P., and Long, A. D. (2001). A Bayesian framework for the analysis of microarray expression data: Regularized t-test and statistical inferences of gene changes. Bioinformatics 17, 509-519.
4. Baranzini, S. E., and Hauser, S. L. (2002). Large-scale gene-expression studies and the challenge of multiple sclerosis. Genome. Biol. 3, 1027.
5. Bennett, L., Palucka, A. K., Arce, E., Cantrell, V., Borvak, J., Banchereau, J., and Pascual, V. (2003). Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J. Exp. Med. 197, 711-723.
6. Bittner, M., Meltzer, P., Chen, Y., Jiang, Y., Seftor, E., Hendrix, M., Radmacher, M., Simon, R., Yakhini, Z., Ben-Dor, A., Sampas, N., Dougherty, E., Wang, E., Marincola, F., Gooden, C., Lueders J., Glatfelter, A., Pollock, P., Carpten, J., Gillanders, E., Leja, D., Dietrich, K., Beaudry, C., Berens, M., Alberts, D., and Sondak, V. (2000). Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 406, 536-540.
7. Brody, J. P., Williams, B. A., Wold, B. J., and Quake, S. R. (2002). Significance and statistical errors in the analysis of DNA microarray data. Proc. Natl. Acad. Sci. USA 99, 12975-12978.
8. Brown, M. P., Grundy, W. N., Lin, D., Cristianini, N., Sugnet, C. W., Furey, T. S., Ares, M., Jr., and Haussler, D. (2000). Knowledge-based analysis of microarray gene expression data by using support vector machines. Proc. Natl. Acad. Sci. USA 97, 262-267.
9. Butte, A. J., Tamayo, P., Slonim, D., Golub, T. R., and Kohane, I. S. (2000). Discovering functional relationships between RNA expression and chemotherapeutic susceptibility using relevance networks. Proc. Natl. Acad. Sci. USA 97, 12182-12186.
10. Campanaro, S., Romualdi, C., Fanin, M., Celegato, B., Pacchioni, B., Trevisan, S., Laveder, P., De Pitta, C., Pegoraro, E., Hayashi, Y. K., Valle, G., Angelini, C., and Lanfranchi, G. (2002). Gene expression profiling in dysferlinopathies using a dedicated muscle microarray. Hum. Mol. Genet. 11, 3283-3298.
11. Caskey, L. S., Fuller, G. N., Bruner, J. M., Yung, W. K., Sawaya, R. E., Holland, E. C., and Zhang, W. (2000). Toward a molecular classification of the gliomas: Histopathology, molecular genetics, and gene expression profiling. Histol. Histopathol. 15, 971-981.
12. Chopra, A., Brown, K. M., Rood, B. R., Packer, R. J., and MacDonald, T. J. (2003). The use of gene expression analysis to gain insights into signaling mechanisms of metastatic medulloblastoma. Pediatr. Neurosurg. 39, 68-74.
13. Colangelo, V., Schurr, J., Ball, M. J., Pelaez, R. P., Bazan, N. G., and Lukiw, W. J. (2002). Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: Transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling. J. Neurosci. Res. 70, 462-473.
14. Cooper, J. D. (2003). Progress towards understanding the neurobiology of Batten disease or neuronal ceroid lipofuscinosis. Curr. Opin. Neurol. 16, 121-128.
15. Copur, M. S., Ledakis, P., and Bolton, M. (2002). Molecular profiling of lymphoma. N. Engl. J. Med. 347, 1376-1377.
16. Dudoit, S., Yang, Y. H., Speed, T. P., and Callow, M. J. (2002). Statistical methods for identifying differentially expressed genes in replicated cDNA microarray experiments. Statistica Sinica 12, 111-139.
17. Dyment, D. A., and Ebers, G. C. (2002). An array of sunshine in multiple sclerosis. N. Engl. J. Med. 347, 1445-1447.
18. Eisen, M. B., Spellman, P. T., Brown, P. O., and Botstein, D. (1998). Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA 95, 14863-14868.
19. Ginsberg, S. D., Hemby, S. E., Lee, V. M., Eberwine, J. H., and Trojanowski, J. Q. (2000). Expression profile of transcripts in Alzheimer's disease tangle-bearing CA1 neurons. Ann. Neurol. 48, 77-87.
20. Golub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., Bloomfield, C. D., and Lander, E. S. (1999). Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring. Science 286, 531-537.
21. Greenberg, S. A. (2001a). DNA microarray gene expression analysis technology and its application to neurological disorders. Neurology 57, 755-761.
22. Greenberg, S. A. (2001b). Theory and application of metric choices for DNA microarray expression analysis technologies. Masters Thesis, Massachusetts Institute of Technology.
23. Greenberg, S. A., Sanoudou, D., Haslett, J. N., Kohane, I. S., Kunkel, L. M., Beggs, A. H., and Amato, A. A. (2002). Molecular profiles of inflammatory myopathies. Neurology 59, 1170-1182.
24. Han, G. M., Chen, S. L., Shen, N., Ye, S., Bao, C. D., and Gu, Y. Y. (2003). Analysis of gene expression profiles in human systemic lupus erythematosus using oligonucleotide microarray. Genes. Immun. 4, 177-186.
25. Haslett, J. N., Sanoudou, D., Kho, A. T., Bennett, R. R., Greenberg, S. A., Kohane, I. S., Beggs, A. H., and Kunkel, L. M. (2002). Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle. Proc. Natl. Acad. Sci. USA 99, 15000-15005.
26. Hata, R., Masumura, M., Akatsu, H., Li, F., Fujita, H., Nagai, Y., Yamamoto, T., Okada, H., Kosaka, K., Sakanaka, M., and Sawada, T. (2001). Up-regulation of calcineurin Abeta mRNA in the Alzheimer's disease brain: Assessment by cDNA microarray. Biochem. Biophys. Res. Commun. 284, 310-316.
27. Hedenfalk, I., Duggan, D., Chen, Y., Radmacher, M., Bittner, M., Simon, R., Meltzer, P., Gusterson, B., Esteller, M., Kallioniemi, O. P., Wilfond, B., Borg, A., and Trent, J. (2001). Gene-expression profiles in hereditary breast cancer. N. Engl. J. Med. 344, 539-548.
28. Hernan, R., Fasheh, R., Calabrese, C., Frank, A. J., Maclean, K. H., Allard, D., Barraclough, R., and Gilbertson, R. J. (2003). ERBB2 up-regulates S100A4 and several other prometastatic genes in medulloblastoma. Cancer. Res. 63, 140-148.
29. Ho, L., Guo, Y., Spielman, L., Petrescu, O., Haroutunian, V., Purohit, D., Czernik, A., Yemul, S., Aisen, P. S., Mohs, R., and Pasinetti, G. M. (2001). Altered expression of a-type but not b-type synapsin isoform in the brain of patients at high risk for Alzheimer's disease assessed by DNA microarray technique. Neurosci. Lett. 298, 191-194.
30. Huang, J., Qi, R., Quackenbush, J., Dauway, E., Lazaridis, E., and Yeatman, T. (2001). Effects of ischemia on gene expression. J. Surg. Res. 99, 222-227.
31. Ishigaki, S., Niwa, J., Ando, Y., Yoshihara, T., Sawada, K., Doyu, M., Yamamoto, M., Kato, K., Yotsumoto, Y., and Sobue, G. (2002). Differentially expressed genes in sporadic amyotrophic lateral sclerosis spinal cords-screening by molecular indexing and subsequent cDNA microarray analysis. FEBS Lett. 531, 354-358.
32. Khan, J., Wei, J. S., Ringner, M., Saal, L. H., Ladanyi, M., Westermann, F., Berthold, F., Schwab, M., Antonescu, C. R., Peterson, C., and Meltzer, P. S. (2001). Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Nat. Med. 7, 673-679.
33. Kim, S., Dougherty, E. R., Shmulevich, L., Hess, K. R., Hamilton, S. R., Trent, J. M., Fuller, G. N., and Zhang, W. (2002). Identification of combination gene sets for glioma classification. Mol. Cancer. Ther. 1, 1229-1236.
34. Kohane, I. S., Kho, A., and Butte, A. J. (2002). Microarrays for an Integrative Genomics. MIT Press, Cambridge.
35. Lock, C., Hermans, G., Pedotti, R., Brendolan, A., Schadt, E., Garren, H., Langer-Gould, A., Strober, S., Cannella, B., Allard, J., Klonowski, P., Austin, A., Lad, N., Kaminski, N., Galli, S. J., Oksenberg, J. R., Raine, C. S., Heller, R., and Steinman, L. (2002). Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 8, 500-508.
36. Lonnstedt, I., and Speed, T. (2002). Replicated microarray data. Statistica Sinica 12, 31-46.
37. Loring, J. F., Wen, X., Lee, J. M., Seilhamer, J., and Somogyi, R. (2001). A gene expression profile of Alzheimer's disease. DNA Cell Biol. 20, 683-695.
38. Luo, Z., and Geschwind, D. H. (2001). Microarray applications in neuroscience. Neurobiol. Dis. 8, 183-193.
39. MacDonald, T. J., Brown, K. M., LaFleur, B., Peterson, K., Lawlor, C., Chen, Y., Packer, R. J., Cogen, P., and Stephan, D. A. (2001). Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease. Nat. Genet. 29, 143-152.
40. Magrath, I. (2002). Molecular characteristics of diffuse large-B-cell lymphoma. N. Engl. J. Med. 346, 1998-1999.
41. Malaspina, A., Kaushik, N., and de Belleroche, J. (2001). Differential expression of 14 genes in amyotrophic lateral sclerosis spinal cord detected using gridded cDNA arrays. J. Neurochem. 77, 132-145.
42. Mayanil, C. S., George, D., Freilich, L., Miljan, E. J., Mania-Farnell, B., McLone, D. G., and Bremer, E. G. (2001). Microarray analysis detects novel Pax3 downstream target genes. J. Biol. Chem. 276, 49299-49309.
43. Mirnics, K. (2001). Microarrays in brain research: The good, the bad and the ugly. Nat. Rev. Neurosci. 2, 444-447.
44. Mufson, E. J., Counts, S. E., and Ginsberg, S. D. (2002). Gene expression profiles of cholinergic nucleus basalis neurons in Alzheimer's disease. Neurochem. Res. 27, 1035-1048.
45. Mukasa, A., Ueki, K., Matsumoto, S., Tsutsumi, S., Nishikawa, R., Fujimaki, T., Asai, A., Kirino, T., and Aburatani, H. (2002). Distinction in gene expression profiles of oligodendrogliomas with and without allelic loss of 1p. Oncogene 21, 3961-3968.
46. Mycko, M. P., Papoian, R., Boschert, U., Raine, C. S., and Selmaj, K. W. (2003). cDNA microarray analysis in multiple sclerosis lesions: Detection of genes associated with disease activity. Brain 126, 1048-1057.
47. Nielsen, T. O., West, R. B., Linn, S. C., Alter, O., Knowling, M. A., O'Connell J. X., Zhu, S., Fero, M., Sherlock, G., Pollack, J. R., Brown, P. O., Botstein, D., and van de Rijn, M. (2002). Molecular characterisation of soft tissue tumours: A gene expression study. Lancet 359, 1301-1307.
48. Noguchi, S., Tsukahara, T., Fujita, M., Kurokawa, R., Tachikawa, M., Toda, T., Tsujimoto, A., Arahata, K., and Nishino, I. (2003). cDNA microarray analysis of individual Duchenne muscular dystrophy patients. Hum. Mol. Genet. 12, 595-600.
49. Nutt, C. L., Mani, D. R., Betensky, R. A., Tamayo, P., Cairncross, J. G., Ladd, C., Pohl, U., Hartmann, C., McLaughlin, M. E., Batchelor, T. T., Black, P. M., von Deimling, A., Pomeroy, S. L., Golub, T. R., and Louis, D. N. (2003). Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. Cancer Res. 63, 1602-1607.
50. Pasinetti, G. M. (2001). Use of cDNA microarray in the search for molecular markers involved in the onset of Alzheimer's disease dementia. J. Neurosci. Res. 65, 471-476.
51. Perou, C. M., Sorlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., Fluge, O., Pergamenschikov, A., Williams, C., Zhu, S. X., Lonning, P. E., Borresen-Dale, A. L., Brown, P. O., and Botstein, D. (2000). Molecular portraits of human breast tumours. Nature 406, 747-752.
52. Pomeroy, S. L., Tamayo, P., Gaasenbeek, M., Sturla, L. M., Angelo, M., McLaughlin, M. E., Kim, J. Y., Goumnerova, L. C., Black, P. M., Lau, C., Allen, J. C., Zagzag, D., Olson, J. M., Curran, T., Wetmore, C., Biegel, J. A., Poggio, T., Mukherjee, S., Rifkin, R., Califano, A., Stolovitzky, G., Louis, D. N., Mesirov, J. P., Lander, E. S., and Golub, T. R. (2002). Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 415, 436-442.
53. Quackenbush, J. (2001). Computational analysis of microarray data. Nat. Rev. Genet. 2, 418-427.
54. Radmacher, M. D., McShane, L. M., and Simon, R. (2002). A paradigm for class prediction using gene expression profiles. J. Comput. Biol. 9, 505-511.
55. Ramanathan, M., Weinstock-Guttman, B., Nguyen, L. T., Badgett, D., Miller, C., Patrick, K., Brownscheidle, C., and Jacobs, L. (2002). In vivo gene expression revealed by cDNA arrays: The pattern in relapsing-remitting multiple sclerosis patients compared with normal subjects. J. Neuroimmunol. 116, 213-219.
56. Ramaswamy, S., Tamayo, P., Rifkin, R., Mukherjee, S., Yeang, C. H., Angelo, M., Ladd, C., Reich, M., Latulippe, E., Mesirov, J. P., Poggio, T., Gerald, W., Loda, M., Lander, E. S., and Golub, T. R. (2001). Multiclass cancer diagnosis using tumor gene expression signatures. Proc. Natl. Acad. Sci. USA 98, 15149-15154.
57. Reiner, A., Yekutieli, D., and Benjamini, Y. (2003). Identifying differentially expressed genes using false discovery rate controlling procedures. Bioinformatics 19, 368-375.
58. Rickman, D. S., Bobek, M. P., Misek, D. E., Kuick, R., Blaivas, M., Kurnit, D. M., Taylor, J., and Hanash, S. M. (2001). Distinctive molecular profiles of high-grade and low-grade gliomas based on oligonucleotide microarray analysis. Cancer Res. 61, 6885-6891.
59. Rosenwald, A., Wright, G., Chan, W. C., Connors, J. M., Campo, E., Fisher, R. I., Gascoyne, R. D., Muller-Hermelink, H. K., Smeland, E. B., Giltnane, J. M., Hurt, E. M., Zhao, H., Averett, L., Yang, L., Wilson, W. H., Jaffe, E. S., Simon, R., Klausner, R. D., Powell, J., Duffey, P. L., Longo, D. L., Greiner, T. C., Weisenburger, D. D., Sanger, W. G., Dave, B. J., Lynch, J. C., Vose, J., Armitage, J. O., Montserrat, E., Lopez-Guillermo, A., Grogan, T. M., Miller, T. P., LeBlanc, M., Ott, G., Kvaloy, S., Delabie, J., Holte, H., Krajci, P., Stokke, T., and Staudt, L. M. (2002). The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N. Engl. J. Med. 346, 1937-1947.
60. Sanoudou, D., Haslett, J. N., Kho, A. T., Guo, S., Gazda, H. T., Greenberg, S. A., Lidov, H. G., Kohane, I. S., Kunkel, L. M., and Beggs, A. H. (2003). Expression profiling reveals altered satellite cell numbers and glycolytic enzyme transcription in nemaline myopathy muscle. Proc. Natl. Acad. Sci. USA 100, 4666-4671.
61. Sauter, G., and Simon, R. (2002). Predictive molecular pathology. N. Engl. J. Med. 347, 1995-1996.
62. Schubert, C. M. (2003). Microarray to be used as routine clinical screen. Nat. Med. 9, 9.
63. Shoemaker, D. D., and Linsley, P. S. (2002). Recent developments in DNA microarrays. Curr. Opin. Microbiol. 5, 334-337.
64. Simon, R., Radmacher, M. D., Dobbin, K., and McShane, L. M. (2003). Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification. J. Natl. Cancer. Inst. 95, 14-18.
65. Sorlie, T., Perou, C. M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Thorsen, T., Quist, H., Matese, J. C., Brown, P. O., Botstein, D., Eystein Lonning, P., and Borresen-Dale, A. L. (2001). Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. USA 98, 10869-10874.
66. Specht, K., Richter, T., Muller, U., and Walch, A. (2000). Quantitative gene expression analysis in microdissected archival tissue by real-time RT-PCR. J. Mol. Med. 78, B27.
67. Steinman, L. (2001). Multiple sclerosis and gene expression profiling. Adv. Exp. Med. Biol. 490, 109-112.
68. Steinman, L., and Zamvil, S. (2003). Transcriptional analysis of targets in multiple sclerosis. Nat. Rev. Immunol. 3, 483-492.
69. Storey, J. D., and Tibshirani, R. (2003). Statistical significance for genomewide studies. Proc. Natl. Acad. Sci. USA 100, 9440-9445.
70. Sturla, L. M., Fernandez-Teijeiro, A., and Pomeroy, S. L. (2003). Application of microarrays to neurological disease. Arch. Neurol. 60, 676-682.
71. Sturzebecher, S., Wandinger, K. P., Rosenwald, A., Sathyamoorthy, M., Tzou, A., Mattar, P., Frank, J. A., Staudt, L., Martin, R., and McFarland, H. F. (2003). Expression profiling identifies responder and non-responder phenotypes to interferon-beta in multiple sclerosis. Brain 126, 1419-1429.
72. Tezak, Z., Hoffman, E. P., Lutz, J. L., Fedczyna, T. O., Stephan, D., Bremer, E. G., Krasnoselska-Riz, I., Kumar, A., and Pachman, L. M. (2002). Gene expression profiling in DQA1*0501+ children with untreated dermatomyositis: A novel model of pathogenesis. J. Immunol. 168, 4154-4163.
73. Tompkins, S. M., and Miller, S. D. (2002). An array of possibilities for multiple sclerosis. Nat. Med. 8, 451-453.
74. Tsukahara, T., and Arahata, K. (2003). A comparative gene expression analysis of Emery-Dreifuss muscular dystrophy using a cDNA microarray. Methods Mol. Biol. 217, 253-262.
75. Tusher, V. G., Tibshirani, R., and Chu, G. (2001). Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA 98, 5116-5121.
76. van de Vijver, M. J., He, Y. D., van't Veer, L. J., Dai, H., Hart, A. A., Voskuil, D. W., Schreiber, G. J., Peterse, J. L., Roberts, C., Marton, M. J., Parrish, M., Atsma, D., Witteveen, A., Glas, A., Delahaye, L., van der Velde, T., Bartelink, H., Rodenhuis, S., Rutgers, E. T., Friend, S. H., and Bernards, R. (2002). A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med. 347, 1999-2009.
77. Van Deerlin, V., Gill, L., and Nelson, P. (2002). Optimizing Gene Expression Analysis in Archival Brain Tissue. Neurochemical Research 27, 993-1003.
78. van't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., Schreiber, G. J., Kerkhoven, R. M., Roberts, C., Linsley, P. S., Bernards, R., and Friend, S. H. (2002). Gene expression profiling predicts clinical outcome of breast cancer. Nature 415, 530-536.
79. Walker, D. G., Lue, L. F., and Beach, T. G. (2001). Gene expression profiling of amyloid beta peptide-stimulated human post-mortem brain microglia. Neurobiol. Aging 22, 957-966.
80. Wandinger, K. P., Sturzebecher, C. S., Bielekova, B., Detore, G., Rosenwald, A., Staudt, L. M., McFarland, H. F., and Martin, R. (2001). Complex immunomodulatory effects of interferon-beta in multiple sclerosis include the upregulation of T helper 1-associated marker genes. Ann. Neurol. 50, 349-357.
81. Watson, M. A., Perry, A., Budhjara, V., Hicks, C., Shannon, W. D., and Rich, K. M. (2001). Gene expression profiling with oligonucleotide microarrays distinguishes World Health Organization grade of oligodendrogliomas. Cancer Res. 61, 1825-1829.
82. Whitney, L. W., Becker, K. G., Tresser, N. J., Caballero-Ramos, C. I., Munson, P. J., Prabhu, V. V., Trent, J. M., McFarland, H. F., and Biddison, W. E. (1999). Analysis of gene expression in mutiple sclerosis lesions using cDNA microarrays. Ann. Neurol. 46, 425-428.
83. Whitney, L. W., Ludwin, S. K., McFarland, H. F., and Biddison, W. E. (2001). Microarray analysis of gene expression in multiple sclerosis and EAE identifies 5-lipoxygenase as a component of inflammatory lesions. J. Neuroimmunol. 121, 40-48.
84. Ye, S., Pang, H., Gu, Y. Y., Hua, J., Chen, X. G., Bao, C. D., Wang, Y., Zhang, W., Qian, J., Tsao, B. P., Hahn, B. H., Chen, S. L., Rao, Z. H., and Shen, N. (2003 Oct). Protein interaction for an interferon-inducible systemic lupus associated gene, IFIT1. Rheumatology (Oxford) 42(10), 1155-1163.
85. Yoon, J. W., Kita, Y., Frank, D. J., Majewski, R. R., Konicek, B. A., Nobrega, M. A., Jacob, H., Walterhouse, D., and Iannaccone, P. (2002). Gene expression profiling leads to identification of GLI1-binding elements in target genes and a role for multiple downstream pathways in GLI1-induced cell transformation. J. Biol. Chem. 277, 5548-5555.